Sign in

NCT02408406Completed

PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers

PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum

Source: ClinicalTrials.gov · Last updated 27 Jun 2024

Brief summary (registry, in English)

This partially randomized pilot clinical trial develops and studies a software program, called PatientCareAnywhere, to see whether it can help patients communicate with their doctors and other healthcare providers, and educate themselves about their cancer and treatment options. A program that can help patients learn about their cancer and treatment options, and allows the patient's healthcare providers to receive their questionnaire results, may help patients identify and get help to treat their symptoms.

Status (registry)
Completed
Study type
Interventional
Enrollment
140 (actual)
First submitted
31 Mar 2015
Start date
7 Jul 2015
Primary completion date
19 Jun 2024
Lead sponsor
City of Hope Medical Center
NCT number
NCT02408406

What you commit to

  • Study type: Interventional
  • Participants enrolled: 140
  • From 7 Jul 2015 to the primary completion date, 19 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • PHASE I AIM 1: Clinical evidence of cognitive or psychological impairment
  • PHASE I AIM 3.1: Clinical evidence of cognitive or psychological impairment
  • PHASE I AIM 3.2: Clinical evidence of cognitive or psychological impairment
  • PHASE II AIM 2: Clinical evidence of cognitive or psychological impairment

Other

  • PHASE I AIM 1 (STAKEHOLDER INPUT) EXCLUSION
  • PHASE I AIM 1: Prisoners and pregnant women
  • PHASE I AIM 3.1 (EVALUATION STUDY) EXCLUSION
  • PHASE I AIM 3.1: Prisoners and pregnant women
  • PHASE I AIM 3.2 (PILOT STUDY) EXCLUSION
  • PHASE I AIM 3.2: Prisoners and pregnant women
  • PHASE I AIM 3.2: Currently participating in other psychosocial studies
  • PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) EXCLUSION
  • PHASE II AIM 2: Prisoners and pregnant women
  • PHASE II AIM 2: Currently participating in other psychosocial studies

Who the study is looking for

  • PHASE I AIM 1 (STAKEHOLDER INPUT)
  • PHASE I AIM 1: Malignant diagnosis in any cancer type at any stage
  • PHASE I AIM 1: Receiving any type of cancer treatment
  • PHASE I AIM 1: Life expectancy of at least six months
  • PHASE I AIM 1: Current outpatient status
  • PHASE I AIM 1: Fluent in English
  • PHASE I AIM 1: Internet access at home
  • PHASE I AIM 3.1 (EVALUATION STUDY)
  • PHASE I AIM 3.1: Malignant diagnosis in any cancer type at any stage
  • PHASE I AIM 3.1: Receiving any type of cancer treatment
  • PHASE I AIM 3.1: Life expectancy of at least six months
  • PHASE I AIM 3.1: Current outpatient status
  • PHASE I AIM 3.1: Fluent in English
  • PHASE I AIM 3.1: Internet access at home
  • PHASE I AIM 3.2 (PILOT STUDY)
  • PHASE I AIM 3.2: Malignant diagnosis in breast, gynecologic (GYN), genitourinary (GU) cancer at any stage
  • PHASE I AIM 3.2: Receiving surgery and/or chemotherapy treatment
  • PHASE I AIM 3.2: Life expectancy of at least six months
  • PHASE I AIM 3.2: Current outpatient status (participation will be suspended during hospitalization)
  • PHASE I AIM 3.2: Fluent in English
  • PHASE I AIM 3.2: Internet access at home
  • PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL)
  • PHASE II AIM 2: Malignant diagnosis of breast, lung, or colorectal cancer at any stage
  • PHASE II AIM 2: Receiving any type of cancer treatment
  • PHASE II AIM 2: Life expectancy of at least six months
  • PHASE II AIM 2: Current medical oncology outpatient status (participation will be suspended during hospitalization)
  • PHASE II AIM 2: Fluent in English
  • PHASE II AIM 2: Internet access at home

Age in the registry: 21 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
City of Hope Medical Center
Coordinator of this site? Confirm its status
DuarteUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.